Skip to content

Clinical trials

Completed Carcinoma, Transitional Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Completed Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20151
20162
20172
20182
20194
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Incyte Corporation2
Basilea Pharmaceutica1
Bayer1
Eli Lilly and Company1
Genentech, Inc.1
Gritstone bio, Inc.1
Hoffmann-La Roche1
Incyte Biosciences International Sàrl1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell16
Urinary Bladder Neoplasms7
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis3
Uterine Cervical Neoplasms3
Carcinoma, Hepatocellular2
Carcinoma, Merkel Cell2
Colorectal Neoplasms2
Mesothelioma2
Nasopharyngeal Carcinoma2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.